Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis

MLA

Mimpen, M., et al. “Prognostic Value of Natural Killer Cell/T Cell Ratios for Disease Activity in Multiple Sclerosis.” Mimpen , M , Muris , AH , Rolf , L , Gerlach , O , Kuhle , J , Hupperts , R , Smolders , J & Damoiseaux , J 2021 , ’ Prognostic Value of Natural Killer Cell/T Cell Ratios for Disease Activity in Multiple Sclerosis ’ , European Journal of Neurology , Vol. 28 , No. 3 , Pp. 901-909 , 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313631267&authtype=sso&custid=ns315887.

APA

Mimpen, M., Muris, A., Rolf, L., Gerlach, O., Kuhle, J., Hupperts, R., Smolders, J., & Damoiseaux, J. (2021). Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis. Mimpen , M , Muris , AH , Rolf , L , Gerlach , O , Kuhle , J , Hupperts , R , Smolders , J & Damoiseaux , J 2021 , ’ Prognostic Value of Natural Killer Cell/T Cell Ratios for Disease Activity in Multiple Sclerosis ’ , European Journal of Neurology , Vol. 28 , No. 3 , Pp. 901-909 .

Chicago

Mimpen, M, Ah Muris, L Rolf, O Gerlach, J Kuhle, R Hupperts, Joost Smolders, and J Damoiseaux. 2021. “Prognostic Value of Natural Killer Cell/T Cell Ratios for Disease Activity in Multiple Sclerosis.” Mimpen , M , Muris , AH , Rolf , L , Gerlach , O , Kuhle , J , Hupperts , R , Smolders , J & Damoiseaux , J 2021 , ’ Prognostic Value of Natural Killer Cell/T Cell Ratios for Disease Activity in Multiple Sclerosis ’ , European Journal of Neurology , Vol. 28 , No. 3 , Pp. 901-909 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313631267&authtype=sso&custid=ns315887.